Drug Interactions between Linzess and ranitidine
This report displays the potential drug interactions for the following 2 drugs:
- Linzess (linaclotide)
Interactions between your drugs
No interactions were found between Linzess and ranitidine. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Linzess is in the drug class guanylate cyclase-C agonists.
- Linzess is used to treat the following conditions:
- Ranitidine is in the drug class H2 antagonists.
Ranitidine is used to treat the following conditions:
- Cutaneous Mastocytosis
- Duodenal Ulcer
- Duodenal Ulcer Prophylaxis
- Erosive Esophagitis
- Gastric Ulcer Maintenance Treatment
- Gastrointestinal Hemorrhage
- Hiatal Hernia
- Laryngopharyngeal Reflux
- Pathological Hypersecretory Conditions
- Stomach Ulcer
- Stress Ulcer Prophylaxis
- Surgical Prophylaxis
- Zollinger-Ellison Syndrome
Drug and food interactions
Applies to: Linzess (linaclotide)
Taking linaclotide with food may increase gastrointestinal side effects such as diarrhea, abdominal pain, and gas. The absorption of any other oral medication you may take can be affected if you develop frequent or severe diarrhea. To reduce the risk of gastrointestinal intolerance, linaclotide should be taken on an empty stomach at least 30 minutes prior to the first meal of the day. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.